Back

Evaluation of resistant starch from teff (Eragrostis tef) grain as a film coating material for colon-targeted drug delivery

Teshome, Y. G.-M.; Belete, A. G.-M.; Gebre-Mariam, T.

2024-08-08 pharmacology and toxicology
10.1101/2024.08.06.606940 bioRxiv
Show abstract

Teff (Eragrostis tef, family Poaceae) is a native cereal crop widely grown in Ethiopia, containing approximately 73% carbohydrates, of which about 30% is resistant starch. This study evaluates resistant starch extracted from teff grain as a film coating material for colon-targeted delivery of metronidazole, used as a model drug. Starch was extracted from teff and resistant starch was isolated from the total starch. Metronidazole core tablets were prepared by wet granulation, compressed, and coated with a resistant starch-based film. The physicochemical properties of the tablets were evaluated in vitro. To prevent premature film disruption caused by the swelling of amylose, a dominant component of resistant starch, a water-insoluble polymer, ethylcellulose, was added. Various proportions of amylose and ethylcellulose were used as film coating materials and evaluated in simulated conditions to determine the optimal combination for drug release in the colon, but not in the upper gastrointestinal tract. The results of the dissolution and fermentation studies indicated the best film coating proportions of amylose to ethylcellulose and the corresponding thicknesses in percentage of total weight gain were: 1:1 ratio at 6% thickness, 1:2 ratio at 4% and 6% thickness, and 1:3 ratio at 2% and 4% thickness. The targeted drug release of the film material is attributed to bacterial enzyme digestion of the resistant starch component in the colon. The digestion of resistant starch creates pores in the ethylcellulose film scaffold, leading to the disruption of the film and release of the drug exclusively in the colon, where the bacterial microflora reside. Based on these results, resistant starch from teff grain shows potential as a colon-targeting excipient.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 1%
47.2%
2
Pharmaceutics
24 papers in training set
Top 0.1%
19.1%
50% of probability mass above
3
Scientific Reports
3612 papers in training set
Top 31%
3.3%
4
Frontiers in Pharmacology
111 papers in training set
Top 1.0%
2.5%
5
BioMed Research International
28 papers in training set
Top 0.6%
2.5%
6
PLOS Neglected Tropical Diseases
466 papers in training set
Top 4%
1.5%
7
Molecular Pharmaceutics
16 papers in training set
Top 0.2%
1.4%
8
BMC Research Notes
33 papers in training set
Top 0.5%
1.4%
9
Pharmaceuticals
34 papers in training set
Top 0.7%
1.2%
10
International Journal of Biological Macromolecules
76 papers in training set
Top 1%
1.1%
11
Cureus
68 papers in training set
Top 4%
1.0%
12
ACS Omega
105 papers in training set
Top 3%
1.0%
13
Microbiology Spectrum
469 papers in training set
Top 9%
1.0%
14
Antimicrobial Agents and Chemotherapy
187 papers in training set
Top 2%
0.9%
15
International Journal of Molecular Sciences
494 papers in training set
Top 14%
0.9%
16
Journal of Immunology Research
12 papers in training set
Top 0.4%
0.9%
17
Molecules
39 papers in training set
Top 1%
0.9%
18
Journal of Hospital Infection
29 papers in training set
Top 0.5%
0.6%
19
Pharmacology Research & Perspectives
11 papers in training set
Top 0.5%
0.5%
20
F1000Research
88 papers in training set
Top 5%
0.5%
21
Biomedicine & Pharmacotherapy
42 papers in training set
Top 2%
0.5%
22
International Journal of Antimicrobial Agents
15 papers in training set
Top 0.6%
0.5%